Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > January 2003

Next month »

31-Jan-2003

Drug discovery moves up a gear

31-Jan-2003 - German LION bioscience has launched an integration platform that aims to speed up drug discovery by integrating cross-functional information from a variety of databases and...

30-Jan-2003

Valentis wins ruling

30-Jan-2003 - US Valentis announced that its wholly-owned subsidiary, PolyMASC Pharmaceuticals, has received a favourable ruling from the Japanese Patent Office in regard to patent invalidation proceedings...

28-Jan-2003

AAC drives submissions to the FDA

28-Jan-2003 - AAC Consulting Group, the regulatory consulting subsidiary of contract research organisation Kendle International, has signed an agreement with two toxicologists - Gary Flamm and James...

Ecopia discovery

28-Jan-2003 - Canadian drug development company Ecopia BioSciences on Monday announced that it had filed patent applications for the first two novel compounds using its proprietary drug...

Pharma in Japan: gaining the competitive edge

28-Jan-2003 - As in-licensing opportunities are reduced and competition for market share in Japan increases with the rising penetration of western pharma companies, domestic mid-cap players must...

Accreditation for food packaging inspection body

28-Jan-2003 - London zoo was the setting last week for UK inspection body Select QA to formally receive certification from the United Kingdom Accreditation Service, involving the...

Pharma packaging: reducing lead times for copy changes

28-Jan-2003 - Alcan Pharma Center, a US division of flexible packaging unit Alcan Packaging, has installed a new four colour Rotomec 3000-5 ES gravure printing press, with...

11-Jan-2003

Strong earnings for Molecular Devices

11-Jan-2003 - US company Molecular Devices, a supplier of bioanalytical measurement systems, announced its revenues and earnings for the quarter and year ended 31 December, 2002. Revenues...

King buys Elan drugs

11-Jan-2003 - King Pharmaceuticals is to buy the rights to two of Elan Corp.'s drugs in the United States and Puerto Rico for $850 million. The purchase...

10-Jan-2003

Aventis and Bayer call off joint venture plans

10-Jan-2003 - Franco-German drugmaker Aventis and Germany's Bayer have agreed not to pursue their plans to create a joint venture in the field of biological products. The...

09-Jan-2003

Voridian contract for Eastman

09-Jan-2003 - Emerson Process Management has received a multi-year contract from Voridian, a division of Eastman Chemical, to upgrade automation systems at Voridian's polyethylene terephthalate (PET) polymers...

07-Jan-2003

Degussa divestments complete

07-Jan-2003 - German chemicals company Degussa has sold its Frankfurt/Main-based biopharmaceutical company Zentaris to Canadian firm AEterna Laboratories for approximately €50 million, the company said last week....

06-Jan-2003

Rhodia continues focus on core activities

06-Jan-2003 - French chemicals company Rhodia is to sell its UK-based brewing and enzymes businesses to US biotech company Genencor International in a bid to strengthen its...

Next month »